In a new online survey, eighty-five percent of people who experience diabetic nerve pain said that their pain was one of the top three most bothersome complications of their diabetes. Despite the fact that people with diabetic nerve pain recognize the condition's impact on their lives and eighty-four percent of those surveyed said they have discussed the condition with a healthcare provider, just slightly less than half of respondents (49 percent) were treating their pain. Complete news at...
Continuous Positive Airway Pressure (CPAP) is the most common treatment for obstructive sleep apnea (OSA). Except for tracheotomy, it is also the most effective treatment for OSA. CPAP is basically a computerized air pump that delivers pressurized air through a hose and then through a nasal interface into the patient's throat. The pressurized air splints open the upper airways, preventing the airflow pauses (apneas) and airflow... Complete news at...
Complete news at...
ImThera Medical, Inc. announced that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA). More than 800,000 patients in the US are annually diagnosed with OSA. While Continuous Positive Airway Pressure (CPAP) remains as the established therapy, studies show that up to 50% of patients do not comply with CPAP. Complete news at...
More than 12 million people in the U.S. suffer from sleep apnea, most common among the overweight and obese. More than just loud snoring, it can lead to high blood pressure, stroke, cardiovascular disease and a poor quality of life. For years, doctors have told patients with sleep apnea that their best bet for alleviating it would be to lose weight, but there's been very little research-based evidence to prove that. Complete news at...
Complete news at...
Complete news at...
Wednesday, September 30, 2009
WUSTL Research Finds Individual Cells Isolated From The Biological Clock Can Keep Daily Time, But Are Unreliable
WUSTL Research Finds Individual Cells Isolated From The Biological Clock Can Keep Daily Time, But Are Unreliable
Alexis Webb enters a small room at Washington University in St. Louis with walls, floor and ceiling painted dark green, shuts the door, turns off the lights and bends over a microscope in a black box draped with black cloth. Through the microscope, she can see a single nerve cell on a glass cover slip glowing dimly. The glow tells her the isolated nerve cell is busy keeping time. Webb, a graduate fellow in the Neuroscience Ph.D. Program, working with Erik Herzog, Ph.D.
Eating At The Wrong Time Could Be Fueling The Obesity Epidemic
Eat less, exercise more. Now there is new evidence to support adding another "must" to the weight-loss mantra: eat at the right time of day. A Northwestern University study has found that eating at irregular times -- the equivalent of the middle of the night for humans, when the body wants to sleep -- influences weight gain. The regulation of energy by the body's circadian rhythms may play a significant role.
Saving Daylight, Increasing Danger: Daylight Saving Time Leads To Less Sleep, More Injuries On The Job
Every March, most Americans welcome the switch to daylight saving time because of the longer days, but also dread losing an hour of sleep after they move their clocks forward. Now a new study shows that losing just an hour of sleep could pose some dangerous consequences for those in hazardous work environments. The findings are reported in the September issue of the Journal of Applied Psychology, which is published by the American Psychological Association.
Sanofi-Aventis Receives Complete Response Letter From The FDA For Eplivanserin (Ciltyri(R)) Submission
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Author has Rare Sleep Disorder
George Dawes Green is an author of thrillers including, in 1995, "The Juror" and, in 2009, "Ravens." Writing, or any occupation where a person can set his own hours, is ideal for George Dawes Green, because he has a rare sleep disorder where his hours of sleeping and waking fall later every day. This is known as free-running circadian rhythm sleep disorder.This disorder is related to day and night,to light and darkness and it is...
Alexis Webb enters a small room at Washington University in St. Louis with walls, floor and ceiling painted dark green, shuts the door, turns off the lights and bends over a microscope in a black box draped with black cloth. Through the microscope, she can see a single nerve cell on a glass cover slip glowing dimly. The glow tells her the isolated nerve cell is busy keeping time. Webb, a graduate fellow in the Neuroscience Ph.D. Program, working with Erik Herzog, Ph.D.
Eating At The Wrong Time Could Be Fueling The Obesity Epidemic
Eat less, exercise more. Now there is new evidence to support adding another "must" to the weight-loss mantra: eat at the right time of day. A Northwestern University study has found that eating at irregular times -- the equivalent of the middle of the night for humans, when the body wants to sleep -- influences weight gain. The regulation of energy by the body's circadian rhythms may play a significant role.
Saving Daylight, Increasing Danger: Daylight Saving Time Leads To Less Sleep, More Injuries On The Job
Every March, most Americans welcome the switch to daylight saving time because of the longer days, but also dread losing an hour of sleep after they move their clocks forward. Now a new study shows that losing just an hour of sleep could pose some dangerous consequences for those in hazardous work environments. The findings are reported in the September issue of the Journal of Applied Psychology, which is published by the American Psychological Association.
Sanofi-Aventis Receives Complete Response Letter From The FDA For Eplivanserin (Ciltyri(R)) Submission
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Author has Rare Sleep Disorder
George Dawes Green is an author of thrillers including, in 1995, "The Juror" and, in 2009, "Ravens." Writing, or any occupation where a person can set his own hours, is ideal for George Dawes Green, because he has a rare sleep disorder where his hours of sleeping and waking fall later every day. This is known as free-running circadian rhythm sleep disorder.This disorder is related to day and night,to light and darkness and it is...
Subscribe to:
Posts (Atom)
